论文信息 - A phase 1b dose-escalation study of BYL719 plus binimetinib (MEK162) in patients with selected advanced solid tumors. - 字舞流文

A phase 1b dose-escalation study of BYL719 plus binimetinib (MEK162) in patients with selected advanced solid tumors.

J. Desai | D. Juric | J. Soria | F. Ringeisen | U. Banerji | H. Maacke | F. Hourcade‐Potelleret | A. Azaro | A. Kaag | Rajkumar Radhakrishnan | J. Ahnert | Sunil Sharma | Analia Azaro